Moderna

Stories 1 - 20 |  Next >>

RFK Jr. Pick Wipes Billions Off the Value of Vaccine Firms

Companies including Pfizer, Moderna dropped sharply after Trump announcement

(Newser) - Thursday was a good day for Robert F. Kennedy Jr. and a bad day for companies that make vaccines. As President-elect Trump announced that Kennedy will be his nominee to lead the Department of Health and Human Services, stocks in top vaccine makers dropped sharply, wiping billions of dollars off...

Updated COVID Shots to Be Available in Days
New COVID Shots Are Coming
Aug 22, 2024 3:44 PM CDT

New COVID Shots Are Coming

FDA clears vaccines, and Pfizer and Moderna are ready to ship

(Newser) - Federal regulators approved updated COVID-19 vaccines on Thursday, shots designed to more closely target recent virus strains—and ideally whatever variants cause trouble this winter, too. With the Food and Drug Administration's clearance, Pfizer and Moderna are set to begin shipping millions of doses, which should be available in...

US Will Pay Moderna $176M to Develop a Bird Flu Vaccine

Funds will pay for continued development of same mRNA technology used in COVID vaccines

(Newser) - The US government will pay the vaccine maker Moderna $176 million to develop a pandemic vaccine that could be used to treat bird flu in people as cases in dairy cows continue to mount across the country, federal officials announced Tuesday. The funds are targeted for release through the US...

We're Not Far From a Lyme Disease Vaccine

As cases rise, Pfizer and Moderna focus attention on fighting tick-borne bacteria

(Newser) - There hasn't been a human vaccine for Lyme disease on the market in the US for 20 years, but that could change in as little as two years. Pfizer and Valneva have begun late-stage clinical trials on their vaccine candidate, VLA15, and say it could be ready for approval...

FDA Clears Bivalent COVID Boosters for Kids 5 and Up

The CDC now has to sign off

(Newser) - The US on Wednesday authorized updated COVID-19 boosters for children as young as 5, seeking to expand protection ahead of an expected winter wave. Tweaked boosters rolled out for Americans 12 and older last month, doses modified to target today's most common and contagious omicron relative. While there wasn'...

Moderna Sues Pfizer Over COVID Vaccine

Company sues rival, alleging patent infringement on mRNA technology

(Newser) - The biggest names in COVID vaccines are now embroiled in a legal fight. Moderna sued Pfizer and its German partner BioNTech on Friday, alleging patent infringement over the technology used to make the COVID shots, reports the Verge . Moderna accused its rivals of essentially stealing the mRNA technology it developed...

Wait for the Next Booster, Officials Tell Adults Under 50

Moderna, Pfizer assure government updated omicron version will be ready for fall

(Newser) - Federal health officials have decided against approving a second booster shot of the coronavirus vaccine this summer for adults under 50, because a retooled version is so close to being ready. Pfizer and Moderna have assured the government their new boosters will be rolled out no later than September, the...

FDA Advisers Endorse Vaccines Starting at 6 Months

Age group is the only one without access to COVID vaccines in US

(Newser) - COVID-19 shots for US infants, toddlers, and preschoolers moved a step closer to reality on Wednesday. The Food and Drug Administration's vaccine advisers gave a thumbs-up to vaccines from Moderna and Pfizer for the littlest kids. The outside experts voted unanimously that the benefits of the shots outweigh any...

FDA Posts Analysis of Pfizer Shots for Kids Under 5

Says the kid-sized dose appears to be safe and effective

(Newser) - Update: The FDA on Sunday posted its analysis of Pfizer’s COVID-19 vaccine for children under age 5, announcing that the kid-sized doses do appear to be safe and effective. The agency posted a similar analysis of Moderna's vaccine for the youngest age group last week. Next up: Wednesday'...

CDC Panel Backs Booster for Ages 5-11
CDC: Children
5-11 Should
Get a Booster
updated
May 19, 2022 6:55 PM CDT

CDC: Children 5-11 Should Get a Booster

Rise in coronavirus cases prompts advisers' decision

(Newser) - Update: This file has been updated throughout with the CDC's decision. Children ages 5 to 11 should get a booster dose of Pfizer's COVID-19 vaccine, the Centers for Disease Control announced Thursday. An advisory panel had made the recommendation earlier in the day. The move opens a third...

Moderna's New CFO Was Ousted After One Day

Jorge Gomez will get $700K severance package

(Newser) - Moderna says David Meline, its former finance chief, will be returning to the role after an extremely short retirement. His successor, Jorge Gomez, became the vaccine maker's chief financial officer on Monday. He left the company on Tuesday after his former employer, dental products maker Dentsply Sirona, disclosed that...

Big Move From Moderna on Shots for Youngest Kids

Pharma company submits data to FDA, asks regulators to OK COVID shots for under-6 set

(Newser) - Moderna on Thursday asked US regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer. Frustrated families are waiting impatiently for a chance to protect the nation's littlest kids as all around...

Moderna Says COVID Vaccine Is Safe for Babies, Toddlers

Company to seek authorization for low doses for kids under 6

(Newser) - Moderna's COVID-19 vaccine works in babies, toddlers, and preschoolers, the company announced Wednesday—and if regulators agree it could mean a chance to finally start vaccinating the littlest kids by summer, per the AP . Moderna said in the coming weeks it would ask regulators in the US and Europe...

Moderna to FDA: Authorize 4th Dose for All Adults

Drugmaker's reasoning: provide flexibility for providers to determine who needs one

(Newser) - Drugmaker Moderna asked the FDA on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults, the AP reports. The request is broader than rival pharmaceutical company Pfizer's request earlier this week for the regulator to approve a booster shot for all...

FDA Gives Full Approval to Moderna Vaccine

Serious side effects have proved to be very rare

(Newser) - Moderna announced Monday that US health regulators have granted full approval to its COVID-19 vaccine, a shot that's been given to tens of millions of Americans since its emergency authorization over a year ago. The action by the Food and Drug Administration means the agency has completed the same...

Omicron-Specific Booster Trials Are Now Underway

Moderna cites 'long-term threat demonstrated by omicron's immune escape'

(Newser) - The first participant has received a shot in Moderna's Phase 2 clinical trial of an omicron-specific vaccine booster. Moderna, which made the announcement Wednesday, expects to enroll 600 adults in the US study, including some who have already received a booster shot, per Reuters . "We are reassured by...

'Lot of Infections' From Omicron After 4th Dose: Trial

In preliminary study from Israel, the first of its kind, antibodies rise after 2nd booster, infections persist

(Newser) - Preliminary results are in on a clinical trial testing the efficacy of a fourth COVID shot, the world's first, and when it comes to omicron, that booster isn't doing the job researchers had hoped for. The Times of Israel reports that, in a study that began last month...

Scientists Announce Big Find on Multiple Sclerosis
Scientists Announce Big Find
on Multiple Sclerosis
NEW STUDY
Jan 14, 2022 7:35 AM CST

Scientists Announce Big Find on Multiple Sclerosis

Findings 'strongly suggest' Epstein-Barr virus is 'a cause and not a consequence of MS'

(Newser) - Researchers say more treatments for multiple sclerosis may be possible after finding a likely "initial trigger" of the auto immune disease. It's unknown what exactly causes MS, a condition affecting 2.8 million people in which immune system cells attack the protective coating on nerve fibers, though some...

Good News on Moderna Booster
Good
News on
Moderna
Booster
Dec 20, 2021 8:33 AM CST

Good News on Moderna Booster

Early lab results suggests third shot provides significant protection against omicron

(Newser) - Lab results from Moderna add to health officials' chorus on omicron: Get a booster. The company said Monday that preliminary results suggests a third shot of its vaccine provides significant protection against the new variant. The usual half-dose booster raised antibody levels 37-fold, while a full-dose booster—typically given to...

CDC Panel Backs Other Vaccines Over J&J's
CDC:
Get Pfizer or
Moderna,
Not J&J
UPDATED
Dec 17, 2021 2:51 AM CST

CDC: Get Pfizer or Moderna, Not J&J

CDC makes official new recommendation

(Newser) - Update: The CDC is now officially taking the stance that that "mRNA vaccines are preferred over [Johnson & Johnson's] Janssen COVID-19 vaccine for the prevention of COVID-19 for those 18 years of age and over." Within hours of a panel making that recommendation, the CDC director accepted...

Stories 1 - 20 |  Next >>
Most Read on Newser